| 11884742 |
Methods for treating conditions associated with MASP-2 dependent complement activation |
Hans-Wilhelm Schwaeble, Clark E. Tedford, Thomas Dudler, Gregory A. Demopulos |
2024-01-30 |
| 11613589 |
Compositions for inhibiting MASP-2 dependent complement activation |
Thomas Dudler, Wayne R. Gombotz, Clark E. Tedford, Anita Kavlie, Urs Beat Hagemann +2 more |
2023-03-28 |
| 10683367 |
Compositions for inhibiting MASP-2 dependent complement activation |
Thomas Dudler, Wayne R. Gombotz, Clark E. Tedford, Anita Kavlie, Urs Beat Hagemann +2 more |
2020-06-16 |
| 10047165 |
Compositions for inhibiting MASP-2 dependent complement activation |
Thomas Dudler, Wayne R. Gombotz, Clark E. Tedford, Anita Kavlie, Urs Beat Hagemann +2 more |
2018-08-14 |
| 9475885 |
Compositions for inhibiting MASP-2 dependent complement activation |
Thomas Dudler, Wayne R. Gombotz, Clark E. Tedford, Anita Kavlie, Urs Beat Hagemann +2 more |
2016-10-25 |
| 9011860 |
Compositions for inhibiting MASP-2 dependent complement activation |
Thomas Dudler, Wayne R. Gombotz, Clark E. Tedford, Anita Kavlie, Urs Beat Hagemann +2 more |
2015-04-21 |
| 8840893 |
Methods for treating conditions associated with MASP-2 dependent complement activation |
Hans-Wilhelm Schwaeble, Clark E. Tedford, Thomas Dudler, Gregory A. Demopulos |
2014-09-23 |
| 8652477 |
Methods for treating disseminated intravascular coagulation by inhibiting MASP-2 dependent complement activation |
Hans-Wilhelm Schwaeble, Thomas Dudler, Clark E. Tedford, Gregory A. Demopulos |
2014-02-18 |
| 7919094 |
Methods for treating conditions associated with MASP-2 dependent complement activation |
Hans-Wilhelm Schwaeble, Cordula Margaret Stover, Clark E. Tedford, Teizo Fujita |
2011-04-05 |
| 6333034 |
Process for inhibiting complement activation via the alternative pathway |
Rekha Gupta-Bansal, Kurt R. Brunden |
2001-12-25 |
| 5348942 |
Therapeutic uses of bactericidal/permeability increasing protein products |
Roger G. Little, Helene Gazzano-Santoro |
1994-09-20 |